What is the state of the art in addiction research? How do we measure recovery? These, and other questions dominated presentations on systematic
Death after rapid opioid taper
Relapse to opioid use is common after rapid opioid withdrawal. As a result, short-term taper of opioid agonist/partial agonist medications - such as
Better medical education: One solution to the opioid crisis
Opioid overdose is a complex problem, no one solution is the best. But effective interventions can help manage opioid addiction. Yet, many effective
Dr Wood tells the forum recipe for research-centre success
In a talk at the 2017 National Institute of Drug Abuse meeting on June 17th, Dr Evan Wood pondered lessons learned and success tips derived from his
Does alcohol use change after shift to Methadose?
Do people drink more when they switch to Methadose? It is 10 times more concentrated than methadone - proven treatment of opioid use disorder. We did
Double trouble: opioids and pain among people with substance use disorders
Against the use of opioids for chronic non-cancer pain to people who have active substance use disorders advises the third recommendation in the new
Bring Audrey back: Teaching medical students about substance disorders
When is the best time to teach medical students about substance related disorders? In a new commentary published online in Annals of Internal
Naloxone and Irish Primary Care Practitioners
We wanted to know what General Practitioners’ (GP) views and experiences of opioid addiction, overdose care and naloxone provision are. Naloxone is an
Two birds with one stone: physicians training in research
Combined training in addiction medicine and research is feasible and acceptable for physicians - a new study shows; however, there are important